Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.80
-1.10%
After-hours: Aug 15, 2025, 04:16 PM EDT
Enlivex Therapeutics Fail-to-Deliver
Total FTD Shares
211
Below Average
FTD / Avg. Volume
0.10%
Low Impact
1-Year Change
47.6%
Positive Trend
FTD Chart
As of Jul 10, 2025,
Enlivex Therapeutics Ltd. has
211
shares failed to deliver, representing 0.10%
of the average daily volume of
203,111
shares. Over the past year, the monthly average FTD is
2,750
shares, with the current level 92% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 10, 2025 | 1.34 | 211 | -88.66% |
| Jun 30, 2025 | 1.12 | 1.86K | +705.19% |
| May 22, 2025 | 0.9621 | 231 | -76.28% |
| Apr 23, 2025 | 0.92 | 974 | +147.84% |
| Mar 27, 2025 | 1.01 | 393 | +145.63% |
| Feb 27, 2025 | 1.03 | 160 | -93.86% |
| Jan 29, 2025 | 1.11 | 2.6K | +1196.02% |
| Dec 26, 2024 | 1.25 | 201 | -90.23% |
| Nov 29, 2024 | 1.14 | 2.06K | -90.37% |
| Oct 25, 2024 | 1.47 | 21.36K | +405.49% |
| Sep 30, 2024 | 1.68 | 4.22K | +17.85% |
| Aug 30, 2024 | 1.3 | 3.58K | +646.88% |
| Jul 30, 2024 | 1.33 | 480 | -72.82% |
| Jun 28, 2024 | 1.42 | 1.77K | -70.73% |
| May 29, 2024 | 1.31 | 6.03K | +465.51% |
| Apr 29, 2024 | 1.66 | 1.07K | -67.08% |
| Mar 28, 2024 | 3.79 | 3.24K | +34.59% |
| Feb 27, 2024 | 3.06 | 2.41K | +2308.00% |
| Jan 29, 2024 | 2.54 | 100 | -89.54% |
| Dec 29, 2023 | 2.7 | 956 | +5.29% |
| Nov 30, 2023 | 1.84 | 908 | +157.95% |
| Oct 31, 2023 | 1.33 | 352 | +0.57% |
| Sep 28, 2023 | 1.5 | 350 | +1196.30% |
| Aug 14, 2023 | 2.65 | 27 | -65.38% |
| Jul 31, 2023 | 2.56 | 78 | +77.27% |
| Jun 30, 2023 | 2.63 | 44 | -91.09% |
| May 30, 2023 | 2.63 | 494 | +233.78% |
| Apr 27, 2023 | 2.89 | 148 | -97.49% |
| Mar 31, 2023 | 3.64 | 5.89K | +342.49% |
| Feb 24, 2023 | 3.84 | 1.33K | +18928.57% |
| Jan 30, 2023 | 4.43 | 7 | n/a |